Doris Trapin

890 total citations
21 papers, 329 citations indexed

About

Doris Trapin is a scholar working on Immunology, Infectious Diseases and Immunology and Allergy. According to data from OpenAlex, Doris Trapin has authored 21 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 5 papers in Infectious Diseases and 5 papers in Immunology and Allergy. Recurrent topics in Doris Trapin's work include Immune Cell Function and Interaction (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Doris Trapin is often cited by papers focused on Immune Cell Function and Interaction (6 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Immunodeficiency and Autoimmune Disorders (5 papers). Doris Trapin collaborates with scholars based in Austria, Russia and Germany. Doris Trapin's co-authors include Winfried F. Pickl, Klaus G. Schmetterer, Bernhard Kratzer, Tatjana Hirschmugl, Heidrun Boztug, Alexander Egle, Daniela Asslaber, Leo Kager, Kaan Boztuǧ and Wolfgang Holter and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Doris Trapin

19 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Doris Trapin Austria 10 177 78 55 55 50 21 329
Joseena Iype Switzerland 9 154 0.9× 33 0.4× 43 0.8× 28 0.5× 113 2.3× 12 379
Anja Troeger Germany 12 170 1.0× 104 1.3× 106 1.9× 15 0.3× 31 0.6× 35 493
Elisangela Santos-Valente Austria 10 376 2.1× 61 0.8× 62 1.1× 10 0.2× 31 0.6× 12 503
Zonghong Shao China 12 228 1.3× 52 0.7× 50 0.9× 8 0.1× 21 0.4× 68 384
Kinga Hosszu United States 11 292 1.6× 52 0.7× 37 0.7× 12 0.2× 25 0.5× 25 390
William Loo United States 9 249 1.4× 21 0.3× 33 0.6× 54 1.0× 26 0.5× 11 382
Gabriele Begemann Germany 8 286 1.6× 34 0.4× 31 0.6× 46 0.8× 13 0.3× 10 340
V. Granger United Kingdom 11 162 0.9× 47 0.6× 67 1.2× 9 0.2× 48 1.0× 15 467
Edwin van Mirre Netherlands 6 252 1.4× 67 0.9× 28 0.5× 28 0.5× 12 0.2× 6 413
Charles A. Filion Canada 6 222 1.3× 50 0.6× 34 0.6× 31 0.6× 76 1.5× 7 333

Countries citing papers authored by Doris Trapin

Since Specialization
Citations

This map shows the geographic impact of Doris Trapin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Doris Trapin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Doris Trapin more than expected).

Fields of papers citing papers by Doris Trapin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Doris Trapin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Doris Trapin. The network helps show where Doris Trapin may publish in the future.

Co-authorship network of co-authors of Doris Trapin

This figure shows the co-authorship network connecting the top 25 collaborators of Doris Trapin. A scholar is included among the top collaborators of Doris Trapin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Doris Trapin. Doris Trapin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kratzer, Bernhard, et al.. (2025). Moloney Murine Leukemia Virus-like Nanoparticles Pseudo-Typed with SARS-CoV-2 RBD for Vaccination Against COVID-19. International Journal of Molecular Sciences. 26(13). 6462–6462.
2.
Kratzer, Bernhard, Pia Gattinger, Doris Trapin, et al.. (2024). Flow Cytometry-Based Measurement of Antibodies Specific for Cell Surface-Expressed Folded SARS-CoV-2 Receptor-Binding Domains. Vaccines. 12(4). 377–377. 1 indexed citations
3.
Kratzer, Bernhard, et al.. (2024). Macropinocytosis Is the Principal Uptake Mechanism of Antigen-Presenting Cells for Allergen-Specific Virus-like Nanoparticles. Vaccines. 12(7). 797–797. 1 indexed citations
5.
Svatoň, Michael, Raúl Jiménez Heredia, Sebastian K. Eder, et al.. (2023). Evans syndrome caused by a deleterious mutation affecting the adaptor protein SASH3. British Journal of Haematology. 203(4). 678–683.
6.
Kratzer, Bernhard, Katharina Grabmeier‐Pfistershammer, Doris Trapin, et al.. (2023). Mycobacterium avium Complex Infections: Detailed Phenotypic and Functional Immunological Work-Up Is Required despite Genetic Analyses. International Archives of Allergy and Immunology. 184(9). 914–931. 1 indexed citations
7.
Kratzer, Bernhard, Ursula Smole, Lisa Rausch, et al.. (2023). The small molecule inhibitor BX-795 uncouples IL-2 production from inhibition of Th2 inflammation and induces CD4+ T cells resembling iTreg. Frontiers in Immunology. 14. 1094694–1094694. 5 indexed citations
8.
Gattinger, Pia, Bernhard Kratzer, Inna Tulaeva, et al.. (2022). Vaccine based on folded receptor binding domain‐PreS fusion protein with potential to induce sterilizing immunity to SARS‐CoV‐2 variants. Allergy. 77(8). 2431–2445. 18 indexed citations
10.
Harrison, Nicole, Katharina Grabmeier‐Pfistershammer, Alexandra Gráf, et al.. (2021). Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination. Vaccines. 9(8). 908–908. 3 indexed citations
11.
Gerner, Marlene C., Ralf Schmidt, Doris Trapin, et al.. (2020). Attenuation of canonical NF‐κB signaling maintains function and stability of human Treg. FEBS Journal. 288(2). 640–662. 14 indexed citations
12.
Smole, Ursula, et al.. (2020). Allergen alters IL‐2/αIL‐2‐based Treg expansion but not tolerance induction in an allergen‐specific mouse model. Allergy. 75(7). 1618–1629. 11 indexed citations
13.
Schmetterer, Klaus G., Marlene C. Gerner, Ralf Schmidt, et al.. (2019). Overexpression of PDE4A Acts as Checkpoint Inhibitor Against cAMP-Mediated Immunosuppression in vitro. Frontiers in Immunology. 10. 1790–1790. 12 indexed citations
14.
Kratzer, Bernhard, Ursula Smole, Doris Trapin, et al.. (2018). Prevention of allergy by virus‐like nanoparticles (VNP) delivering shielded versions of major allergens in a humanized murine allergy model. Allergy. 74(2). 246–260. 34 indexed citations
15.
Neunkirchner, Alina, Bernhard Kratzer, Ursula Smole, et al.. (2018). Genetic restriction of antigen-presentation dictates allergic sensitization and disease in humanized mice. EBioMedicine. 31. 66–78. 24 indexed citations
16.
Schmidt, Ralf, Sabrina Jutz, Nadine Witzeneder, et al.. (2017). Chloroquine inhibits human CD4+ T-cell activation by AP-1 signaling modulation. Scientific Reports. 7(1). 42191–42191. 37 indexed citations
17.
Boztug, Heidrun, Tatjana Hirschmugl, Wolfgang Holter, et al.. (2016). NF-κB1 Haploinsufficiency Causing Immunodeficiency and EBV-Driven Lymphoproliferation. Journal of Clinical Immunology. 36(6). 533–540. 70 indexed citations
18.
Neunkirchner, Alina, et al.. (2015). CD8+ T Cell Fate and Function Influenced by Antigen-Specific Virus-Like Nanoparticles Co-Expressing Membrane Tethered IL-2. PLoS ONE. 10(5). e0126034–e0126034. 4 indexed citations
19.
Hofbauer, Josefina Piñón, Christoph Heyder, Ursula Denk, et al.. (2011). Development of CLL in the TCL1 transgenic mouse model is associated with severe skewing of the T-cell compartment homologous to human CLL. Leukemia. 25(9). 1452–1458. 74 indexed citations
20.
Zaborsky, Nadja, Josefina Piñón Hofbauer, Thomas Köcher, et al.. (2011). Clonal Diversity of the T Cell Repertoire Predicts Disease Progression in Chronic Lymphocytic Leukaemia. Blood. 118(21). 803–803. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026